Verrica Pharmaceuticals Inc (VRCA) Insider Trading
- $31,527,810.28
- $6,773,027.74
- July 22, 2024
- Matt Davidson
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
July 22, 2024 | CEO | 32,469 | $7.06 | Sell | $229,231.14 | |
July 22, 2024 | Insider | 25,461 | $7.06 | Sell | $179,754.66 | |
Dec. 28, 2023 | Major Shareholder | 126,116 | $7.08 | Buy | $892,901.28 | |
Dec. 26, 2023 | Major Shareholder | 54,652 | $6.49 | Buy | $354,691.48 | |
Dec. 21, 2023 | Major Shareholder | 200,000 | $6.17 | Buy | $1,234,000.00 | |
Dec. 18, 2023 | Major Shareholder | 456,923 | $5.41 | Buy | $2,471,953.43 | |
Dec. 15, 2023 | Major Shareholder | 500,000 | $5.97 | Buy | $2,985,000.00 | |
Nov. 14, 2023 | Insider | 21,580 | $2.93 | Sell | $63,229.40 | |
July 24, 2023 | CEO | 50,677 | $4.83 | Sell | $244,769.91 | |
July 24, 2023 | Insider | 33,789 | $4.83 | Sell | $163,200.87 | |
July 24, 2023 | Director | 200,000 | $5.02 | Buy | $1,004,000.00 | |
July 11, 2022 | Insider | 7,500 | $3.40 | Buy | $25,500.00 | |
July 11, 2022 | Chief Legal Officer | 7,500 | $3.40 | Buy | $25,500.00 | |
July 5, 2022 | Major Shareholder | 1,428,571 | $2.10 | Buy | $2,999,999.10 | |
July 5, 2022 | Insider | 5,714 | $2.10 | Buy | $11,999.40 | |
July 5, 2022 | Director | 238,095 | $2.10 | Buy | $499,999.50 | |
July 5, 2022 | CEO | 23,809 | $2.10 | Buy | $49,998.90 | |
Dec. 2, 2021 | Director | 30,023 | $9.45 | Buy | $283,717.35 | |
June 4, 2021 | CFO | 5,000 | $9.89 | Buy | $49,450.00 | |
June 4, 2021 | CEO | 4,000 | $9.95 | Buy | $39,800.00 | |
June 4, 2021 | Insider | 2,500 | $9.79 | Buy | $24,475.00 | |
March 25, 2021 | Director | 739,830 | $14.75 | Buy | $10,912,492.50 | |
Aug. 24, 2020 | Director | 5,228 | $9.16 | Buy | $47,888.48 | |
Aug. 20, 2020 | Director | 20,000 | $9.09 | Buy | $181,800.00 | |
Aug. 17, 2020 | Director | 6,000 | $6.92 | Buy | $41,520.00 | |
Aug. 13, 2020 | Director | 108,500 | $6.41 | Buy | $695,485.00 | |
Aug. 13, 2020 | CEO | 10,661 | $6.28 | Buy | $66,951.08 | |
Aug. 13, 2020 | CFO | 7,900 | $6.24 | Buy | $49,296.00 | |
Oct. 10, 2019 | Director | 20,886 | $15.08 | Buy | $314,960.88 | |
Sept. 9, 2019 | Major Shareholder | 19,314 | $10.89 | Sell | $210,329.46 | |
Aug. 29, 2019 | Major Shareholder | 2,688 | $10.16 | Sell | $27,310.08 | |
Aug. 9, 2019 | Major Shareholder | 6,313 | $10.49 | Sell | $66,223.37 | |
Aug. 6, 2019 | Major Shareholder | 6,250 | $10.54 | Sell | $65,875.00 | |
Aug. 1, 2019 | Major Shareholder | 10,338 | $11.92 | Sell | $123,228.96 | |
July 29, 2019 | Major Shareholder | 12,058 | $11.40 | Sell | $137,461.20 | |
July 24, 2019 | Major Shareholder | 2,802 | $10.24 | Sell | $28,692.48 | |
July 19, 2019 | Major Shareholder | 10,800 | $10.33 | Sell | $111,564.00 | |
July 16, 2019 | Major Shareholder | 10,490 | $10.93 | Sell | $114,655.70 | |
July 11, 2019 | Major Shareholder | 13,212 | $11.58 | Sell | $152,994.96 | |
July 8, 2019 | Major Shareholder | 12,529 | $11.27 | Sell | $141,201.83 | |
July 2, 2019 | Major Shareholder | 33,521 | $11.63 | Sell | $389,849.23 | |
June 25, 2019 | Major Shareholder | 210 | $10.04 | Sell | $2,108.40 | |
June 13, 2019 | Major Shareholder | 2,131 | $9.65 | Sell | $20,564.15 | |
June 11, 2019 | Major Shareholder | 4,345 | $8.49 | Sell | $36,889.05 | |
June 6, 2019 | Major Shareholder | 5,507 | $7.27 | Sell | $40,035.89 | |
June 3, 2019 | Major Shareholder | 4,110 | $7.36 | Sell | $30,249.60 | |
May 29, 2019 | Major Shareholder | 2,100 | $8.41 | Sell | $17,661.00 | |
May 23, 2019 | Major Shareholder | 2,422 | $8.80 | Sell | $21,313.60 | |
May 20, 2019 | Major Shareholder | 1,800 | $8.95 | Sell | $16,110.00 | |
May 15, 2019 | Major Shareholder | 6,973 | $9.11 | Sell | $63,524.03 |
Insiders are both buying and selling Verrica Pharmaceuticals Inc stock.
The insider traders at Verrica Pharmaceuticals Inc are: Matt Davidson, Ted White, Perceptive Advisors Llc, Paul B Manning, Paul B. Manning, Christopher G Hayes, Joe Bonaccorso, Linda Palczuk, A Brian Davis, John A Stalfort III, Hayes Christopher G., Craig Ballaron, Sean Stalfort, and Chris Degnan
The most active insider trader at Verrica Pharmaceuticals Inc is Matt Davidson with 54 trades.
Matt Davidson has sold the most Verrica Pharmaceuticals Inc stock with a total value of $6,103,171.22.
Paul B. Manning has bought the most Verrica Pharmaceuticals Inc stock with a total value of $22,743,790.00.
The most recent insider trade for Verrica Pharmaceuticals Inc was on July 22, 2024.
The single biggest insider buy for Verrica Pharmaceuticals Inc was from Paul B. Manning with a total value of $10,912,492.50 on March 25, 2021.
The single biggest insider sell for Verrica Pharmaceuticals Inc was from Matt Davidson with a total value of $389,849.23 on July 2, 2019.